Towards Automatic Cartilage Quantification in Clinical Trials - Continuing from the 2019 IWOAI Knee Segmentation Challenge.

MRI cartilage clinical trial deep learning knee

Journal

Osteoarthritis imaging
ISSN: 2772-6541
Titre abrégé: Osteoarthr Imaging
Pays: England
ID NLM: 9918454385406676

Informations de publication

Date de publication:
Mar 2023
Historique:
medline: 1 3 2023
pubmed: 1 3 2023
entrez: 22 7 2024
Statut: ppublish

Résumé

To evaluate whether the deep learning (DL) segmentation methods from the six teams that participated in the IWOAI 2019 Knee Cartilage Segmentation Challenge are appropriate for quantifying cartilage loss in longitudinal clinical trials. We included 556 subjects from the Osteoarthritis Initiative study with manually read cartilage volume scores for the baseline and 1-year visits. The teams used their methods originally trained for the IWOAI 2019 challenge to segment the 1130 knee MRIs. These scans were anonymized and the teams were blinded to any subject or visit identifiers. Two teams also submitted updated methods. The resulting 9,040 segmentations are available online.The segmentations included tibial, femoral, and patellar compartments. In post-processing, we extracted medial and lateral tibial compartments and geometrically defined central medial and lateral femoral sub-compartments. The primary study outcome was the sensitivity to measure cartilage loss as defined by the standardized response mean (SRM). For the tibial compartments, several of the DL segmentation methods had SRMs similar to the gold standard manual method. The highest DL SRM was for the lateral tibial compartment at 0.38 (the gold standard had 0.34). For the femoral compartments, the gold standard had higher SRMs than the automatic methods at 0.31/0.30 for medial/lateral compartments. The lower SRMs for the DL methods in the femoral compartments at 0.2 were possibly due to the simple sub-compartment extraction done during post-processing. The study demonstrated that state-of-the-art DL segmentation methods may be used in standardized longitudinal single-scanner clinical trials for well-defined cartilage compartments.

Identifiants

pubmed: 39036792
doi: 10.1016/j.ostima.2023.100087
pmc: PMC11258861
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Erik B Dam (EB)

University of Copenhagen, Copenhagen, Denmark.

Arjun D Desai (AD)

Stanford University, Stanford, CA USA.

Cem M Deniz (CM)

New York University, Langone Health, New York, NY USA.

Haresh R Rajamohan (HR)

New York University, New York, NY USA.

Ravinder Regatte (R)

New York University, Langone Health, New York, NY USA.

Claudia Iriondo (C)

University of California, San Francisco, CA USA.

Valentina Pedoia (V)

University of California, San Francisco, CA USA.

Sharmila Majumdar (S)

University of California, San Francisco, CA USA.

Mathias Perslev (M)

University of Copenhagen, Copenhagen, Denmark.

Christian Igel (C)

University of Copenhagen, Copenhagen, Denmark.

Akshay Pai (A)

Cerebriu A/S, Copenhagen, Denmark.

Sibaji Gaj (S)

Cleveland Clinic, Cleveland, OH USA.

Mingrui Yang (M)

Cleveland Clinic, Cleveland, OH USA.

Kunio Nakamura (K)

Cleveland Clinic, Cleveland, OH USA.

Xiaojuan Li (X)

Cleveland Clinic, Cleveland, OH USA.

Hasan Maqbool (H)

University of Central Florida, Orlando, FL USA.

Ismail Irmakci (I)

Northwestern University, Evanston, IL USA.

Sang-Eun Song (SE)

University of Central Florida, Orlando, FL USA.

Ulas Bagci (U)

Northwestern University, Evanston, IL USA.

Brian Hargreaves (B)

Stanford University, Stanford, CA USA.

Garry Gold (G)

Stanford University, Stanford, CA USA.

Akshay Chaudhari (A)

Stanford University, Stanford, CA USA.

Classifications MeSH